middle.news
Starpharma and Radiopharm Forge $89M Radiotherapy Collaboration
9:45am on Tuesday 30th of September, 2025 AEST
•
Biotechnology
Read Story
Starpharma and Radiopharm Forge $89M Radiotherapy Collaboration
9:45am on Tuesday 30th of September, 2025 AEST
Key Points
Research and option agreement signed between Starpharma and Radiopharm Theranostics
Development of dendrimer-drug conjugate incorporating Radiopharm’s radiopharmaceutical molecule
Starpharma to receive R&D fees and potential milestone payments up to AUD $89 million
First radiopharmaceutical partnership for Starpharma and first Star Navigator program to formal collaboration
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Starpharma (ASX:SPL)
OPEN ARTICLE